Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (180)
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
24
Price
$27.33
Total Value
$655.81
Shares Held After
81,042
% of Holdings
0.0%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
534
Price
$26.03
Total Value
$13.90K
Shares Held After
81,066
% of Holdings
0.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
7,600
Price
$45.89
Total Value
$348.76K
Shares Held After
519,227
% of Holdings
1.4%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,282
Price
$45.43
Total Value
$194.53K
Shares Held After
526,827
% of Holdings
0.8%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
9,200
Price
$44.43
Total Value
$408.76K
Shares Held After
531,109
% of Holdings
1.7%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
1,506
Price
$4.27
Total Value
$6.43K
Shares Held After
94,630
% of Holdings
1.6%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,905
Price
$4.27
Total Value
$25.21K
Shares Held After
605,408
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
819
Price
$4.27
Total Value
$3.50K
Shares Held After
64,545
% of Holdings
1.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,859
Price
$4.27
Total Value
$7.94K
Shares Held After
157,703
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,036
Price
$4.27
Total Value
$4.42K
Shares Held After
91,428
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$524.99
Total Value
$787.49K
Shares Held After
45,321
% of Holdings
3.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
200
Price
$650.15
Total Value
$130.03K
Shares Held After
17,303
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
1,541
Price
$519.00
Total Value
$799.78K
Shares Held After
11,001
% of Holdings
12.3%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
19,225
% of Holdings
13.5%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
131,210
Price
$9.50
Total Value
$1.25M
Shares Held After
125,386
% of Holdings
51.1%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
10,000
Price
$1.98
Total Value
$19.80K
Shares Held After
366,904
% of Holdings
2.7%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
44,838
Price
$22.59
Total Value
$1.01M
Shares Held After
230,713
% of Holdings
16.3%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
3,092
Price
$38.48
Total Value
$118.98K
Shares Held After
254,280
% of Holdings
1.2%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
4,677
Price
$18.00
Total Value
$84.19K
Shares Held After
156,286
% of Holdings
2.9%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
2,161
Price
$13.64
Total Value
$29.48K
Shares Held After
213,009
% of Holdings
1.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,873
Price
$13.00
Total Value
$232.40K
Shares Held After
90,180
% of Holdings
16.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
24,335
Price
$23.33
Total Value
$567.74K
Shares Held After
208,504
% of Holdings
10.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
75,665
Price
$22.35
Total Value
$1.69M
Shares Held After
232,839
% of Holdings
24.5%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,821
Price
$2.49
Total Value
$24.45K
Shares Held After
2,641,308
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
147
Price
$1.55
Total Value
$227.85
Shares Held After
73,135
% of Holdings
0.2%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,460
Price
$1.55
Total Value
$2.26K
Shares Held After
724,395
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
225
Price
$556.36
Total Value
$125.18K
Shares Held After
45,172
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
990
Price
$555.83
Total Value
$550.27K
Shares Held After
45,397
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
299
Price
$554.45
Total Value
$165.78K
Shares Held After
46,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,201
Price
$553.52
Total Value
$1.22M
Shares Held After
46,686
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,818
Price
$552.61
Total Value
$1.00M
Shares Held After
48,887
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$551.30
Total Value
$808.75K
Shares Held After
50,705
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
384
Price
$550.02
Total Value
$211.21K
Shares Held After
52,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
258
Price
$548.73
Total Value
$141.57K
Shares Held After
52,556
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
658
Price
$548.00
Total Value
$360.58K
Shares Held After
52,814
% of Holdings
1.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
1,530
Price
$35.23
Total Value
$53.90K
Shares Held After
88,840
% of Holdings
1.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
2,531
Price
$34.58
Total Value
$87.52K
Shares Held After
90,370
% of Holdings
2.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
11,008
Price
$23.56
Total Value
$259.37K
Shares Held After
13,579
% of Holdings
44.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,400
Price
$71.97
Total Value
$100.76K
Shares Held After
491,712
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$558.37
Total Value
$22.33K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$557.63
Total Value
$178.44K
Shares Held After
40,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,343
Price
$556.56
Total Value
$747.46K
Shares Held After
40,873
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,942
Price
$555.67
Total Value
$1.63M
Shares Held After
42,216
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,006
Price
$554.75
Total Value
$1.11M
Shares Held After
45,158
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
776
Price
$553.64
Total Value
$429.62K
Shares Held After
47,164
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
993
Price
$552.72
Total Value
$548.86K
Shares Held After
47,940
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.59
Total Value
$353.02K
Shares Held After
48,933
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
118
Price
$549.77
Total Value
$64.87K
Shares Held After
49,573
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
130
Price
$548.75
Total Value
$71.34K
Shares Held After
49,691
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
192
Price
$548.01
Total Value
$105.22K
Shares Held After
49,821
% of Holdings
0.4%
Showing 1–50 of 180 transactions (page 1 of 4)